Date | Title | Description | Source |
15.12.2021 | Checkmate Pharmaceuticals : Corporate Overview – December 20... | Heating Up Cancer Immunotherapy
December 2021
Forward Looking Statement
Certain statements in thi... | marketscre... |
19.11.2021 | Checkmate Pharmaceuticals : Corporate Overview – November 20... | Heating Up Cancer Immunotherapy
November 2021
Forward Looking Statement
Certain statements in thi... | marketscre... |
03.11.2021 | Checkmate Pharmaceuticals Corporate Overview – November 2021... | Heating Up Cancer Immunotherapy
November 2021
Forward Looking Statement
Certain statements in thi... | marketscre... |
28.10.2021 | Checkmate Pharmaceuticals Corporate Overview – October 2021... | Heating Up Cancer Immunotherapy
October 2021
Forward Looking Statement
Certain statements in this... | marketscre... |
04.05.2021 | CHECKMATE PHARMACEUTICALS, INC.
Checkmate Pharmaceuticals :... | CAMBRIDGE, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“... | marketscre... |
23.09.2020 | Healthcare VC Firm Longitude Capital Closes $585M Fund | What You Should Know:
– Healthcare venture capital firm Longitude Capital announces the close of it... | hitconsult... |
23.09.2020 | Longitude Capital Raises $585 Million Fund to Invest in Tran... | - Longitude Venture Partners IV will build on the Firm’s commitment to improve clinical outcomes, en... | marketscre... |
04.08.2020 | IPO Launch: Checkmate Pharmaceuticals Proposes $75 Million I... | - | fprimecapi... |
12.06.2020 | Biotechnology Company Checkmate Pharmaceuticals Raises $85 M... | Checkmate Pharmaceuticals, a clinical-stage biotechnology company that is focused on improving patie... | pulse2.com... |
10.06.2020 | Checkmate Pharmaceuticals Secures $85 Million in Series C Fi... | - | fprimecapi... |
10.06.2020 | Checkmate Pharmaceuticals Raises $85M in Series C Financing | Checkmate Pharmaceuticals, a Cambridge, MA-based clinical stage biotechnology company with a novel a... | finsmes.co... |
10.06.2020 | Checkmate Pharmaceuticals Inks $85M in Series C |
CAMBRIDGE, MA, Checkmate Pharmaceuticals has completed an $85 million Series C financing.
>>... | vcnewsdail... |
10.06.2020 | Checkmate Pharmaceuticals Secures $85 Million in Series C Fi... | - | sofinnova.... |
10.06.2020 | Checkmate Pharmaceuticals Secures $85 Million in Series C Fi... | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Checkmate Pharmaceuticals (Checkmate), a clinical stage biotechno... | citybizlis... |
12.12.2018 | Checkmate Pharmaceuticals Closes $22M Financing | Checkmate Pharmaceuticals Inc., a Cambridge, Mass.-based clinical stage biopharmaceutical company fo... | finsmes.co... |
12.12.2018 | Art Krieg moves from CEO post to CSO at Checkmate; Indiv... | Art Krieg
→ Art Krieg is turning in his spot in the CEO’s suite in exchange for the CSO’s job at ... | endpts.com... |
12.12.2018 | Checkmate Pharmaceuticals Announces CEO Transition and $22 M... | - | fprimecapi... |
05.09.2018 | What's up at Immunocore?; Pfizer nabs a key 'breakthroug... | → What’s up at Immunocore? Vantage is reporting that Immunocore’s chief strategy officer ... | endpts.com... |
13.11.2017 | Arcus Biosciences closes $107M Series C round as industry hu... | Additional therapies are needed to double-down on the tumor and to close any potential escape routes... | medcitynew... |
16.06.2017 | Checkmate Pharmaceuticals Inks $27M Series B |
CAMBRIDGE, MA, Clinical-stage biopharmaceutical company has completed a $27 million Series B prefe... | vcnewsdail... |
15.06.2017 | Checkmate Pharmaceuticals Raises $27 Million Series B | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Checkmate Pharmaceuticals (Checkmate), a clinical-stage biopharma... | citybizlis... |
15.06.2017 | Checkmate Pharmaceuticals Secures $27M Series B Funding | Checkmate Pharmaceuticals, a Cambridge, Mass.-based clinical-stage biopharmaceutical company focused... | finsmes.co... |
12.08.2015 | Daily funding roundup - August 12, 2015 | PokitDoc closed $34M; Infogain secured $63M; Soothe raised $10.6M
If there's a service that I often... | vator.tv/n... |
12.08.2015 | Checkmate Pharmaceuticals Nets $20M Series A |
CAMBRIDGE, MA, Biopharmaceutical company focused on developing novel approaches for cancer immunot... | vcnewsdail... |
12.08.2015 | Checkmate nets $20M to develop drug that boosts checkpoint i... | Checkmate Pharmaceuticals operates on the idea that checkpoint inhibitor therapies would be much mor... | medcitynew... |
12.08.2015 | Checkmate Pharmaceuticals Raises $20M Series A Financing | Checkmate Pharmaceuticals, a Cambridge, MA-based biopharmaceutical company focused on developing nov... | finsmes.co... |
- | Checkmate nets $20M to develop drug that boosts checkpoint i... | The name of the company’s pretty pithy: Checkmate Pharmaceuticals, so-called because its drug in dev... | medcitynew... |
- | Arcus Biosciences closes $107M Series C round as industry hu... | Imagine cancer as a fugitive, hiding in a rundown warehouse. The police (aka the immune system) patr... | medcitynew... |
- | American Cancer Society’s BrightEdge to Invest in Checkmate ... | BrightEdge, LLC, the American Cancer Society’s philanthropic impact fund, today announced its partic... | acsbrighte... |